| Company type | Subsidiary |
|---|---|
| |
| Industry | Biopharmaceuticals |
| Founded | 2018 |
| Fate | Acquired by AbbVie |
| Headquarters | Cambridge, Massachusetts, U.S. |
Number of employees | 355 (2024) |
| Parent | Abbvie |
| Website | cerevel |
Cerevel Therapeutics Holdings, Inc. is an American biotechnology and pharmaceuticals company based in Cambridge, Massachusetts, focused on the development of novel therapies for mental and neurological illnesses.[1]